logo
  

Delivery Hero Invests In Gorillas - Quick Facts

Delivery Hero SE (DHER.DE DLVHF.OB) has invested $235 million in on-demand delivery startup Gorillas Technologies GmbH. Delivery Hero led Gorillas' series C funding round, and now holds approximately 8% in Gorillas.

Based in Berlin, Gorillas provides consumers instant access to essential grocery products. Gorillas operates in nine countries: Belgium, Denmark, France, Germany, Italy, Netherlands, Spain, the United Kingdom and the United States of America.

Niklas Östberg, CEO of Delivery Hero, said: "Delivery Hero is on a mission to advance quick commerce globally and we see Gorillas as one of the leaders in Europe and the US. We truly believe that investing in innovative q-commerce players will benefit the entire industry and set a new standard for what a great customer experience looks like."

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Privately-held biotechnology company On Target Laboratories, Inc. announce that the U.S. Food and Drug Administration or FDA, has approved Cytalux (pafolacianine) for adult patients with ovarian cancer as an adjunct for intraoperative identification of malignant lesions. Cytalux is the first targeted fluorescent imaging agent that illuminates ovarian cancer intraoperatively. The Federal Trade Commission or FTC has ordered Walmart, Amazon, Kroger and certain other large wholesalers and suppliers to provide information to help it study causes of supply chain disruptions. The agency has launched an inquiry to find the reasons for empty shelves and exorbitant prices. Along with Walmart, Amazon.com, and Kroger, the order has been sent to C&S Wholesale Grocers, Associated.. Covid vaccine maker Moderna Inc.'s Chief Executive Stéphane Bancel has predicted that existing COVID-19 vaccines will be much less effective against Omicron than earlier strains, according to the Financial Times.
Follow RTT